Can the diagnostic reliability of the thrombin generation test as a global haemostasis assay be improved? The impact of calcium chloride concentration.

about

Can the diagnostic reliability of the thrombin generation test as a global haemostasis assay be improved? The impact of calcium chloride concentration.

Item

http://www.wikidata.org/entity/Q45864873

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Can the diagnostic reliability ...... alcium chloride concentration.

@en

Can the diagnostic reliability ...... alcium chloride concentration.

@nl

type

Item

label

Can the diagnostic reliability ...... alcium chloride concentration.

@en

Can the diagnostic reliability ...... alcium chloride concentration.

@nl

prefLabel

Can the diagnostic reliability ...... alcium chloride concentration.

@en

Can the diagnostic reliability ...... alcium chloride concentration.

@nl

P1476

Can the diagnostic reliability ...... calcium chloride concentration

@en

P2093

S S Surov

http://www.w3.org/2001/XMLSchema#string

T K Lee

http://www.w3.org/2001/XMLSchema#string

Y Liang

http://www.w3.org/2001/XMLSchema#string

P2860

The calibrated automated thrombogram (CAT): a universal routine test for hyper- and hypocoagulability

Calibrated automated thrombin generation measurement in clotting plasma

Proteolytic activation of human factors IX and X by recombinant human factor VIIa: effects of calcium, phospholipids, and tissue factor

Biology of tissue factor pathway inhibitor.

The mechanism underlying activation of factor IX by factor XIa.

Unifying the mechanism of recombinant FVIIa action: dose dependence is regulated differently by tissue factor and phospholipids.

Insect cell-based expression and characterization of a single-chain variable antibody fragment directed against blood coagulation factor VIII.

Determining the impact of instrument variation and automated software algorithms on the TGT in hemophilia and normalized plasma.

Optimization of the thrombin generation test components to measure potency of factor VIII concentrates.

Clotting factor product administration and same-day occurrence of thrombotic events, as recorded in a large healthcare database during 2008-2013.

P304

466-475

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/HAE.13174

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

M V Ovanesov

L A Parunov

P577

2017-02-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28205396

http://www.w3.org/2001/XMLSchema#string